advertisement
He Y 29
Showing records 1 to 25 | Display all abstracts from He Y106836 Targeting Necroptosis: A Novel Therapeutic Option for Retinal Degenerative Diseases
Zhang Q
International journal of biological sciences 2023; 19: 658-674
106450 CSF tau microtubule-binding region identifies pathological changes in primary tauopathies
Horie K
Nature Medicine 2022; 28: 2547-2554
106320 Valdecoxib Protects against Cell Apoptosis Induced by Endoplasmic Reticulum Stress via the Inhibition of PERK-ATF4-CHOP Pathway in Experimental Glaucoma
Gao Z; Li M
International journal of molecular sciences 2022; 23:
106450 CSF tau microtubule-binding region identifies pathological changes in primary tauopathies
Barthélemy NR
Nature Medicine 2022; 28: 2547-2554
106836 Targeting Necroptosis: A Novel Therapeutic Option for Retinal Degenerative Diseases
Hu XM
International journal of biological sciences 2023; 19: 658-674
106450 CSF tau microtubule-binding region identifies pathological changes in primary tauopathies
Spina S
Nature Medicine 2022; 28: 2547-2554
106320 Valdecoxib Protects against Cell Apoptosis Induced by Endoplasmic Reticulum Stress via the Inhibition of PERK-ATF4-CHOP Pathway in Experimental Glaucoma
Yao F
International journal of molecular sciences 2022; 23:
106836 Targeting Necroptosis: A Novel Therapeutic Option for Retinal Degenerative Diseases
Zhao WJ; Ban XX
International journal of biological sciences 2023; 19: 658-674
106450 CSF tau microtubule-binding region identifies pathological changes in primary tauopathies
VandeVrede L
Nature Medicine 2022; 28: 2547-2554
106320 Valdecoxib Protects against Cell Apoptosis Induced by Endoplasmic Reticulum Stress via the Inhibition of PERK-ATF4-CHOP Pathway in Experimental Glaucoma
Xia X; Duan T
International journal of molecular sciences 2022; 23:
106836 Targeting Necroptosis: A Novel Therapeutic Option for Retinal Degenerative Diseases
Li Y
International journal of biological sciences 2023; 19: 658-674
106450 CSF tau microtubule-binding region identifies pathological changes in primary tauopathies
He Y
Nature Medicine 2022; 28: 2547-2554
106320 Valdecoxib Protects against Cell Apoptosis Induced by Endoplasmic Reticulum Stress via the Inhibition of PERK-ATF4-CHOP Pathway in Experimental Glaucoma
Meng J
International journal of molecular sciences 2022; 23:
106836 Targeting Necroptosis: A Novel Therapeutic Option for Retinal Degenerative Diseases
Huang YX
International journal of biological sciences 2023; 19: 658-674
106450 CSF tau microtubule-binding region identifies pathological changes in primary tauopathies
Paterson RW; Wright BA
Nature Medicine 2022; 28: 2547-2554
106320 Valdecoxib Protects against Cell Apoptosis Induced by Endoplasmic Reticulum Stress via the Inhibition of PERK-ATF4-CHOP Pathway in Experimental Glaucoma
Huang Y
International journal of molecular sciences 2022; 23:
106836 Targeting Necroptosis: A Novel Therapeutic Option for Retinal Degenerative Diseases
Wan H
International journal of biological sciences 2023; 19: 658-674
106450 CSF tau microtubule-binding region identifies pathological changes in primary tauopathies
Day GS
Nature Medicine 2022; 28: 2547-2554
106836 Targeting Necroptosis: A Novel Therapeutic Option for Retinal Degenerative Diseases
He Y
International journal of biological sciences 2023; 19: 658-674
106320 Valdecoxib Protects against Cell Apoptosis Induced by Endoplasmic Reticulum Stress via the Inhibition of PERK-ATF4-CHOP Pathway in Experimental Glaucoma
He Y; Saro A
International journal of molecular sciences 2022; 23:
106450 CSF tau microtubule-binding region identifies pathological changes in primary tauopathies
Davis AA
Nature Medicine 2022; 28: 2547-2554
106836 Targeting Necroptosis: A Novel Therapeutic Option for Retinal Degenerative Diseases
Liao LS
International journal of biological sciences 2023; 19: 658-674
106320 Valdecoxib Protects against Cell Apoptosis Induced by Endoplasmic Reticulum Stress via the Inhibition of PERK-ATF4-CHOP Pathway in Experimental Glaucoma
Huang J
International journal of molecular sciences 2022; 23:
106836 Targeting Necroptosis: A Novel Therapeutic Option for Retinal Degenerative Diseases
Shang L
International journal of biological sciences 2023; 19: 658-674
106450 CSF tau microtubule-binding region identifies pathological changes in primary tauopathies
Karch CM
Nature Medicine 2022; 28: 2547-2554
